PEPTIDE LSARLAF ACTIVATES ALPHA(IIIB)BETA(3) ON RESTING PLATELETS ANDCAUSES RESTING PLATELET AGGREGATE FORMATION WITHOUT PLATELET SHAPE CHANGE

Citation
Jm. Derrick et al., PEPTIDE LSARLAF ACTIVATES ALPHA(IIIB)BETA(3) ON RESTING PLATELETS ANDCAUSES RESTING PLATELET AGGREGATE FORMATION WITHOUT PLATELET SHAPE CHANGE, Thrombosis research, 89(1), 1998, pp. 31-40
Citations number
34
Categorie Soggetti
Hematology,"Peripheal Vascular Diseas
Journal title
ISSN journal
00493848
Volume
89
Issue
1
Year of publication
1998
Pages
31 - 40
Database
ISI
SICI code
0049-3848(1998)89:1<31:PLAAOR>2.0.ZU;2-T
Abstract
Adhesion of resting platelets to fibrinogen was enhanced by a peptide which was designed to bind near the presumptive fibrinogen gamma-chain binding site of the alpha subunit of the integrin alpha(IIb)beta(3). This peptide, but not a scrambled control peptide, induced adhesion of resting platelets to fibronectin, vitronectin, von Willebrand factor, and monovalent (lacks one functional gamma-chain) fibrinogen. Resting platelets not treated with the agonist peptide did not adhere to thes e ligands. Agonist peptide induced adhesion of resting platelets to Fg was not secretion dependent and was inhibited by the monoclonal antib ody 7E3. The agonist peptide caused aggregation of resting platelets o n resting platelets adherent to immobilized Fg without causing platele t shape change. Therefore, the agonist peptide may activate alpha(IIb) beta(3) by directly inducing a conformation change in the receptor on resting platelets. (C) 1998 Elsevier Science Ltd.